Recent Updates
Recently added Catalysts
RIGL Neutral Sentiment Score: 60/100

Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2022 Financial Results and Business Update

Key Takeaway: Rigel Pharmaceuticals, Inc. plans to report its fourth quarter and full year 2022 financial results on March 7, 2023. Following the announcement, a live conference call and webcast will be held to discuss these results and provide a business update. This event emphasizes Rigel's commitment to keeping investors informed. The webcast will also be archived for later access on the company's website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Rigel is set to report its financial results, which may reflect positive business performance.
  • The conference call provides an opportunity for transparency and communication with investors.
  • The webcast will be available for replay, ensuring wider access to information.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Feb. 28, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its fourth quarter and full year 2022 financial results after market close on Tuesday, March 7, 2023. Rigel senior management will follow the announcement with a live conference call and webcast at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the financial results and give an update on the business.
Participants can access the live conference call by dialing 877-407-3088 (domestic) or 201-389-0927 (international). The conference call and accompanying slides will also be webcast live and can be accessed from the Investor Relations section of the company's website at www.rigel.com. The webcast will be archived and available for replay for 90 days after the call via the Rigel website.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.
Contact for Investors & Media:
Rigel Pharmaceuticals, Inc.
SOURCE Rigel Pharmaceuticals, Inc.

21 %

more press release views with

Frequently Asked Questions

When will Rigel Pharmaceuticals announce its financial results?

Rigel Pharmaceuticals will announce its financial results on March 7, 2023.

How can I listen to the Rigel conference call?

You can listen by calling 877-407-3088 domestically or 201-389-0927 internationally.

What time is the Rigel conference call scheduled for?

The conference call is scheduled for 4:30 p.m. Eastern Time.

Where can I access Rigel's webcast of the conference call?

The webcast can be accessed from Rigel's Investor Relations section on their website.

How long will the webcast be available for replay?

The webcast will be available for replay for 90 days after the call.

Last updated: Feb 28, 2023